Kodiak Sciences to Present at the 42nd Annual J.P. Morgan Healthcare Conference
Kodiak Sciences Inc. , a biopharmaceutical company committed to researching, developing and commercializing transformative therapeutics to treat high prevalence retinal diseases, announced today that management will present at the 42nd Annual J.P....
Source: lelezard.com